Reports
Reports
Sale
The alternative cancer treatment market is expected to grow at a CAGR of 17.8% during the forecast period of 2024-2032, driven by the rising incidence of cancer, increased research and innovation in alternative treatments, and the growing preference for holistic and integrative health approaches across the 8 major markets.
Cancer Treatment Market Growth
Cancer Treatment Market Trends
Cancer Treatment Regional Analysis
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Alternative Cancer Treatment Market Overview – 8 Major Markets
3.1 Alternative Cancer Treatment Market Historical Value (2017-2023)
3.2 Alternative Cancer Treatment Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Alternative Cancer Treatment Overview
5.1 Guidelines and Stages
5.2 Pathophysiology
5.3 Screening and Diagnosis
5.4 Treatment Pathway
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
6.3 Risk Assessment and Treatment Success Rate
7 Alternative Cancer Treatment Epidemiology Scenario and Forecast – 8 Major Markets
7.1 8MM Epidemiology Scenario Overview (2017-2032)
7.1.1 Prevalence, by Country
7.1.1.1 U.S.
7.1.1.2 U.K.
7.1.1.3 EU4
7.1.1.4 India
7.1.1.5 Japan
7.1.2 Mortality, by Country
7.1.2.1 U.S.
7.1.2.2 U.K.
7.1.2.3 EU4
7.1.2.4 India
7.1.2.5 Japan
7.1.3 Treatment seeking rate, by Country
7.1.3.1 U.S.
7.1.3.2 U.K.
7.1.3.3 EU4
7.1.3.4 India
7.1.3.5 Japan
8 Alternative Cancer Treatment Market Landscape – 8 Major Markets
8.1 Alternative Cancer Treatment: Developers Landscape
8.1.1 Analysis by Year of Establishment
8.1.2 Analysis by Company Size
8.1.3 Analysis by Region
8.2 Alternative Cancer Treatment: Product Landscape
8.2.1 Analysis by Therapy Type
8.2.2 Analysis by Disease Type
9 Alternative Cancer Treatment Challenges and Unmet Needs
9.1 Treatment Pathway Challenges
9.2 Compliance and Drop-Out Analysis
9.3 Awareness and Prevention Gaps
10 Cost of Treatment
11 Alternative Cancer Treatment Market Dynamics
11.1 Market Drivers and Constraints
11.2 SWOT Analysis
11.2.1 Strengths
11.2.2 Weaknesses
11.2.3 Opportunities
11.2.4 Threats
11.3 PESTEL Analysis
11.3.1 Political
11.3.2 Economic
11.3.3 Social
11.3.4 Technological
11.3.5 Legal
11.3.6 Environment
11.4 Porter’s Five Forces Model
11.4.1 Bargaining Power of Suppliers
11.4.2 Bargaining Power of Buyers
11.4.3 Threat of New Entrants
11.4.4 Threat of Substitutes
11.4.5 Degree of Rivalry
11.5 Key Demand Indicators
11.6 Key Price Indicators
11.7 Industry Events, Initiatives, and Trends
11.8 Value Chain Analysis
12 Alternative Cancer Treatment Market Segmentation (2017-2032) - 8 Major Markets
12.1 Alternative Cancer Treatment Market (2017-2032) by Therapy Type
12.1.1 Market Overview
12.1.2 Hormone Therapies
12.1.3 Acupuncture
12.1.4 Hyperthermia
12.1.5 Dietary Supplements
12.1.6 Ayurveda
12.1.7 Others
12.2 Alternative Cancer Treatment Market (2017-2032) by Disease Type
12.2.1 Market Overview
12.2.2 Gastrointestinal
12.2.3 Lung Cancer
12.2.4 Breast Cancer
12.2.5 Colorectal Cancer
12.2.6 Leukaemia
12.2.7 Lymphoma
12.2.8 Melanoma
12.2.9 Prostate Cancer
12.2.10 Others
12.3 Alternative Cancer Treatment Market (2017-2032) by Region
12.3.1 Market Overview
12.3.2 United States
12.3.3 EU-4 and the United Kingdom
12.3.3.1 Germany
12.3.3.2 France
12.3.3.3 Italy
12.3.3.4 Spain
12.3.3.5 United Kingdom
12.3.4 Japan
12.3.5 India
13 United States Alternative Cancer Treatment Market (2017-2032)
13.1 United States Alternative Cancer Treatment Market Historical Value (2017-2023)
13.2 United States Alternative Cancer Treatment Market Forecast Value (2024-2032)
13.3 United States Alternative Cancer Treatment Market (2017-2032) by Therapy Type
13.3.1 Market Overview
13.3.2 Hormone Therapies
13.3.3 Acupuncture
13.3.4 Hyperthermia
13.3.5 Dietary Supplements
13.3.6 Ayurveda
13.3.7 Others
13.4 United States Alternative Cancer Treatment Market (2017-2032) by Disease Type
13.4.1 Market Overview
13.4.2 Gastrointestinal
13.4.3 Lung Cancer
13.4.4 Breast Cancer
13.4.5 Colorectal Cancer
13.4.6 Leukaemia
13.4.7 Lymphoma
13.4.8 Melanoma
13.4.9 Prostate Cancer
13.4.10 Others
14 EU-4 and United Kingdom Alternative Cancer Treatment Market (2017-2032)
14.1 EU-4 and United Kingdom Alternative Cancer Treatment Market Historical Value (2017-2023)
14.2 EU-4 and United Kingdom Alternative Cancer Treatment Market Forecast Value (2024-2032)
14.3 EU-4 and United Kingdom Alternative Cancer Treatment Market (2017-2032) by Therapy Type
14.3.1 Market Overview
14.3.2 Hormone Therapies
14.3.3 Acupuncture
14.3.4 Hyperthermia
14.3.5 Dietary Supplements
14.3.6 Ayurveda
14.3.7 Others
14.4 EU-4 and United Kingdom Alternative Cancer Treatment Market (2017-2032) by Disease Type
14.4.1 Market Overview
14.4.2 Gastrointestinal
14.4.3 Lung Cancer
14.4.4 Breast Cancer
14.4.5 Colorectal Cancer
14.4.6 Leukaemia
14.4.7 Lymphoma
14.4.8 Melanoma
14.4.9 Prostate Cancer
14.4.10 Others
15 Japan Alternative Cancer Treatment Market
15.1 Japan Alternative Cancer Treatment Market Historical Value (2017-2023)
15.2 Japan Alternative Cancer Treatment Market Forecast Value (2024-2032)
15.3 Japan Alternative Cancer Treatment Market (2017-2032) by Therapy Type
15.3.1 Market Overview
15.3.2 Hormone Therapies
15.3.3 Acupuncture
15.3.4 Hyperthermia
15.3.5 Dietary Supplements
15.3.6 Ayurveda
15.3.7 Others
15.4 Japan Alternative Cancer Treatment Market (2017-2032) by Disease Type
15.4.1 Market Overview
15.4.2 Gastrointestinal
15.4.3 Lung Cancer
15.4.4 Breast Cancer
15.4.5 Colorectal Cancer
15.4.6 Leukaemia
15.4.7 Lymphoma
15.4.8 Melanoma
15.4.9 Prostate Cancer
15.4.10 Others
16 India Alternative Cancer Treatment Market
16.1 India Alternative Cancer Treatment Market (2017-2032) Historical Value (2017-2023)
16.2 India Alternative Cancer Treatment Market (2017-2032) Forecast Value (2024-2032)
16.3 India Alternative Cancer Treatment Market (2017-2032) by Therapy Type
16.3.1 Market Overview
16.3.2 Hormone Therapies
16.3.3 Acupuncture
16.3.4 Hyperthermia
16.3.5 Dietary Supplements
16.3.6 Ayurveda
16.3.7 Others
16.4 India Alternative Cancer Treatment Market (2017-2032) by Disease Type
16.4.1 Market Overview
16.4.2 Gastrointestinal
16.4.3 Lung Cancer
16.4.4 Breast Cancer
16.4.5 Colorectal Cancer
16.4.6 Leukaemia
16.4.7 Lymphoma
16.4.8 Melanoma
16.4.9 Prostate Cancer
16.4.10 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.2 US FDA
17.3 EU EMA
17.4 Japan PMDA
17.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication Year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by Year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Strategic Initiatives
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Market Share by Top 5 Companies
23.2 Innovative Medicine, LLC
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Northwest Natural Health Clinic
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Immunotherapy Institute
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Akesis Life Oncology
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Holistic Bio Spa
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Cancer Center for Healing
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Abramson Cancer Center
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Synthesis Clinic
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Saskatoon Naturopathic Medicine
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Pellegrino Healing Center
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
24 Alternative Cancer Treatment Treatment Drugs - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Payment Methods (Additional Insight)
26.1 Government Funded
26.2 Private Insurance
26.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
*The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.